These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10328866

  • 41. Endogenous tumor necrosis factor exerts its protective function intracellularly against the cytotoxicity of exogenous tumor necrosis factor.
    Okamoto T, Watanabe N, Yamauchi N, Tsuji Y, Tsuji N, Itoh Y, Neda H, Niitsu Y.
    Cancer Res; 1992 Oct 01; 52(19):5278-81. PubMed ID: 1327505
    [Abstract] [Full Text] [Related]

  • 42. Effects of clusterin overexpression on TNFalpha- and TGFbeta-mediated death of L929 cells.
    Humphreys D, Hochgrebe TT, Easterbrook-Smith SB, Tenniswood MP, Wilson MR.
    Biochemistry; 1997 Dec 09; 36(49):15233-43. PubMed ID: 9398251
    [Abstract] [Full Text] [Related]

  • 43. Failure of tumor necrosis factor and interleukin-1 to elicit superoxide production in the mitochondrial matrices of mammalian cells.
    Gardner PR, White CW.
    Arch Biochem Biophys; 1996 Oct 01; 334(1):158-62. PubMed ID: 8837751
    [Abstract] [Full Text] [Related]

  • 44. Role of P2z purinergic receptors in ATP-mediated killing of tumor necrosis factor (TNF)-sensitive and TNF-resistant L929 fibroblasts.
    Pizzo P, Murgia M, Zambon A, Zanovello P, Bronte V, Pietrobon D, Di Virgilio F.
    J Immunol; 1992 Nov 15; 149(10):3372-8. PubMed ID: 1431111
    [Abstract] [Full Text] [Related]

  • 45. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation.
    Shoji Y, Uedono Y, Ishikura H, Takeyama N, Tanaka T.
    Immunology; 1995 Apr 15; 84(4):543-8. PubMed ID: 7790027
    [Abstract] [Full Text] [Related]

  • 46. Transfection of L929 cells with complement subcomponent C1q B-chain antisense cDNA inhibits tumor necrosis factor-alpha binding to mediate cytotoxicity and nitric oxide generation.
    Jiang H, Stewart CA, Tan SY, Fast DJ, Rummage JA, Leu RW.
    Cell Immunol; 1996 Feb 01; 167(2):293-301. PubMed ID: 8603439
    [Abstract] [Full Text] [Related]

  • 47. Association of lysosomal activity with sensitivity and resistance to tumor necrosis factor in murine L929 cells.
    Liddil JD, Dorr RT, Scuderi P.
    Cancer Res; 1989 May 15; 49(10):2722-8. PubMed ID: 2713856
    [Abstract] [Full Text] [Related]

  • 48. The role of iron in the cytotoxicity of tumor necrosis factor.
    Warren S, Torti SV, Torti FM.
    Lymphokine Cytokine Res; 1993 Apr 15; 12(2):75-80. PubMed ID: 8324080
    [Abstract] [Full Text] [Related]

  • 49. Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation.
    Agarwal S, Drysdale BE, Shin HS.
    J Immunol; 1988 Jun 15; 140(12):4187-92. PubMed ID: 2967329
    [Abstract] [Full Text] [Related]

  • 50. Tumor necrosis factor alpha affect hydrocortisone expression in mice adrenal cortex cells mainly through tumor necrosis factor alpha-receptor 1.
    Xia HM, Fang Y, Huang PL.
    Chin Med J (Engl); 2011 Sep 15; 124(17):2728-32. PubMed ID: 22040432
    [Abstract] [Full Text] [Related]

  • 51. [Correlation of cytotoxic activity of mutant forms of tumor necrosis factor alpha with changes in the level of free sphingosine in murine liver].
    Solov'ev AS, Korobko VG, Shingarova LN, Vasil'eva SV, Makhova EV, Alesenko AV.
    Biokhimiia; 1995 Aug 15; 60(8):1283-91. PubMed ID: 7578580
    [Abstract] [Full Text] [Related]

  • 52. Mechanism of the cytotoxic effect of tumor necrosis factor.
    Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N, Urushizaki I.
    Jpn J Cancer Res; 1985 Dec 15; 76(12):1193-7. PubMed ID: 3005210
    [Abstract] [Full Text] [Related]

  • 53. [Tumor necrosis factor (TNF) and oxygen free radicals: potential effects for immunity].
    Ferlat S, Favier A.
    C R Seances Soc Biol Fil; 1993 Dec 15; 187(3):296-307. PubMed ID: 8019909
    [Abstract] [Full Text] [Related]

  • 54. Cloning and characterization of a transforming growth factor beta 1-induced anti-apoptotic adhesion protein TIF2.
    Carey GB, Chang NS.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):283-6. PubMed ID: 9705873
    [Abstract] [Full Text] [Related]

  • 55. Effects of hypoxia on the cytotoxicity mediated by tumor necrosis factor-alpha.
    Naldini A, Cesari S, Bocci V.
    Lymphokine Cytokine Res; 1994 Aug 10; 13(4):233-7. PubMed ID: 7999923
    [Abstract] [Full Text] [Related]

  • 56. Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts.
    Yan T, Oberley LW, Zhong W, St Clair DK.
    Cancer Res; 1996 Jun 15; 56(12):2864-71. PubMed ID: 8665527
    [Abstract] [Full Text] [Related]

  • 57. Cloning of genomic DNA for tumor necrosis factor and efficient expression in CHO cells.
    Korn JH, Mory Y, Ziberstein A, Holtmann H, Revel M, Wallach D.
    Lymphokine Res; 1988 Jun 15; 7(4):349-58. PubMed ID: 3210813
    [Abstract] [Full Text] [Related]

  • 58. Protective role of manganese superoxide dismutase against cigarette smoke-induced cytotoxicity.
    St Clair DK, Jordan JA, Wan XS, Gairola CG.
    J Toxicol Environ Health; 1994 Oct 15; 43(2):239-49. PubMed ID: 7932852
    [Abstract] [Full Text] [Related]

  • 59. SOD2 (MnSOD) does not suppress tumorigenicity or metastasis of human melanoma C8161 cells.
    Miele ME, McGary CT, Welch DR.
    Anticancer Res; 1995 Oct 15; 15(5B):2065-70. PubMed ID: 8572603
    [Abstract] [Full Text] [Related]

  • 60. Evidence for a protein synthesis-dependent and -independent TNF alpha cytolytic mechanism.
    Powell CB, Herzog TJ, Scott JH, Collins JL.
    Gynecol Oncol; 1995 Sep 15; 58(3):327-35. PubMed ID: 7545633
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.